KPTI
Income statement / Annual
Last year (2023), Karyopharm Therapeutics Inc.'s total revenue was $146.03 M,
a decrease of 7.03% from the previous year.
In 2023, Karyopharm Therapeutics Inc.'s net income was -$143.10 M.
See Karyopharm Therapeutics Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$146.03 M
|
$157.07 M
|
$209.82 M
|
$108.09 M
|
$40.89 M
|
$30.34 M
|
$1.61 M
|
$154,000.00
|
$250,000.00
|
$229,000.00
|
| Cost of Revenue |
$5.47 M |
$5.21 M |
$3.40 M |
$2.71 M |
$2.41 M |
$161.37 M |
$107.27 M |
$86.94 M |
$97.74 M |
$60.13 M |
| Gross Profit |
$140.56 M |
$151.86 M |
$206.42 M |
$105.38 M |
$38.49 M |
-$131.04 M |
-$105.67 M |
-$86.78 M |
-$97.49 M |
-$59.90 M |
| Gross Profit Ratio |
0.96 |
0.97 |
0.98 |
0.97 |
0.94 |
-4.32 |
-65.84 |
-563.53 |
-389.98 |
-261.56 |
| Research and Development
Expenses |
$138.22 M
|
$148.66 M
|
$160.84 M
|
$150.81 M
|
$122.34 M
|
$161.37 M
|
$107.27 M
|
$86.94 M
|
$97.74 M
|
$60.13 M
|
| General & Administrative
Expenses |
$131.88 M
|
$145.40 M
|
$143.85 M
|
$126.42 M
|
$0.00
|
$48.85 M
|
$24.87 M
|
$23.95 M
|
$21.58 M
|
$15.95 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$131.88 M
|
$145.40 M
|
$143.85 M
|
$126.42 M
|
$105.42 M
|
$48.85 M
|
$24.87 M
|
$23.95 M
|
$21.58 M
|
$15.95 M
|
| Other Expenses |
-$356,000.00 |
-$83,000.00 |
-$85,000.00 |
$206,000.00 |
-$50,000.00 |
-$33,000.00 |
-$81,000.00 |
$10,000.00 |
-$2,000.00 |
-$27,000.00 |
| Operating Expenses |
$270.10 M |
$294.06 M |
$304.69 M |
$277.23 M |
$227.76 M |
$210.22 M |
$132.14 M |
$110.89 M |
$119.33 M |
$76.08 M |
| Cost And Expenses |
$275.57 M |
$299.28 M |
$308.09 M |
$279.94 M |
$230.17 M |
$210.22 M |
$132.14 M |
$110.89 M |
$119.33 M |
$76.08 M |
| Interest Income |
$10.94 M |
$2.36 M |
$582,000.00 |
$2.82 M |
$5.42 M |
$4.03 M |
$1.70 M |
$1.28 M |
$897,000.00 |
$97,000.00 |
| Interest Expense |
$23.82 M |
$25.00 M |
$26.05 M |
$27.14 M |
$15.65 M |
$2.49 M |
-$1.62 M |
-$1.29 M |
-$895,000.00 |
$1,000.00 |
| Depreciation &
Amortization |
$530,000.00
|
$621,000.00
|
$789,000.00
|
$972,000.00
|
$974,000.00
|
$735,000.00
|
$713,000.00
|
$717,000.00
|
$634,000.00
|
$323,000.00
|
| EBITDA |
-$129.01 M
|
-$139.93 M
|
-$97.77 M
|
-$168.82 M
|
-$183.90 M
|
-$175.89 M
|
-$130.54 M
|
-$110.73 M
|
-$119.08 M
|
-$75.78 M
|
| EBITDA Ratio |
-0.88 |
-0.89 |
-0.47 |
-1.56 |
-4.5 |
-5.8 |
-81.33 |
-719.04 |
-476.3 |
-330.9 |
| Operating Income Ratio
|
-0.89
|
-0.91
|
-0.47
|
-1.59
|
-4.63
|
-5.93
|
-81.33
|
-719.04
|
-476.3
|
-331.21
|
| Total Other
Income/Expenses Net |
-$13.24 M
|
-$22.72 M
|
-$25.55 M
|
-$24.11 M
|
-$10.28 M
|
$1.50 M
|
-$81,000.00
|
$10,000.00
|
-$2,000.00
|
-$27,000.00
|
| Income Before Tax |
-$142.78 M |
-$164.92 M |
-$123.82 M |
-$195.96 M |
-$199.55 M |
-$178.38 M |
-$128.92 M |
-$109.44 M |
-$118.18 M |
-$75.78 M |
| Income Before Tax Ratio
|
-0.98
|
-1.05
|
-0.59
|
-1.81
|
-4.88
|
-5.88
|
-80.32
|
-710.64
|
-472.72
|
-330.9
|
| Income Tax Expense |
$323,000.00 |
$369,000.00 |
$268,000.00 |
$309,000.00 |
$40,000.00 |
$26,000.00 |
$63,000.00 |
$139,000.00 |
-$895,000.00 |
-$69,000.00 |
| Net Income |
-$143.10 M |
-$165.29 M |
-$124.09 M |
-$196.27 M |
-$199.59 M |
-$178.41 M |
-$128.98 M |
-$109.58 M |
-$118.18 M |
-$75.78 M |
| Net Income Ratio |
-0.98 |
-1.05 |
-0.59 |
-1.82 |
-4.88 |
-5.88 |
-80.36 |
-711.54 |
-472.72 |
-330.9 |
| EPS |
-1.25 |
-2.02 |
-1.65 |
-2.72 |
-3.22 |
-3.14 |
-2.81 |
-2.92 |
-3.32 |
-2.43 |
| EPS Diluted |
-1.25 |
-2.02 |
-1.65 |
-2.72 |
-3.22 |
-3.14 |
-2.81 |
-2.92 |
-3.32 |
-2.43 |
| Weighted Average Shares
Out |
$114.22 M
|
$81.87 M
|
$75.22 M
|
$72.04 M
|
$61.96 M
|
$56.78 M
|
$45.90 M
|
$37.52 M
|
$35.62 M
|
$31.14 M
|
| Weighted Average Shares
Out Diluted |
$114.22 M
|
$81.87 M
|
$75.22 M
|
$72.04 M
|
$61.96 M
|
$56.78 M
|
$45.90 M
|
$37.52 M
|
$35.62 M
|
$31.14 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
